Vectorite Biomedical

Vectorite Biomedical EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vectorite Biomedical (4170.TWO) as of Sep 21, 2026 is -21.91 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -25.97 M TWD — a change of -15.65% (higher).

EBITDA

-21.91 MTWD

YoY

-15.65%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vectorite Biomedical is 2026 -21.91 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vectorite Biomedical was 2025 -25.97 M TWD. It decreases by -15.65% higher compared to the previous year.

The Vectorite Biomedical EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-66.01 M TWD
Jan 1, 2019
-90.26 M TWD
Jan 1, 2020
-51.63 M TWD
Jan 1, 2021
-34.81 M TWD
Jan 1, 2022
30.54 M TWD
Jan 1, 2023
-16.13 M TWD
Jan 1, 2024
-25.97 M TWD
Jan 1, 2025
-21.91 M TWD
The Vectorite Biomedical EBITDA history
YEAREBITDAYoY
-21.91 MTWD-15.65%
-25.97 MTWD+61.00%
-16.13 MTWD-152.83%
30.54 MTWD-187.73%
-34.81 MTWD-32.58%
-51.63 MTWD-42.80%
-90.26 MTWD+36.73%
-66.01 MTWD+21.57%
-54.30 MTWD-21.14%
-68.86 MTWD-8.73%
-75.44 MTWD+124.61%
-33.59 MTWD—
Access this data via the Eulerpool API
Get Free API Key

Vectorite Biomedical Stock analysis

What does Vectorite Biomedical do? Vectorite Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vectorite Biomedical stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vectorite Biomedical is -21.91 M TWD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vectorite Biomedical changed from -25.97 M TWD to -21.91 M TWD, representing a -15.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Vectorite Biomedical since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Vectorite Biomedical historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Vectorite Biomedical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Vectorite Biomedical